Target intelligence / Profile preview

Stratum corneum (skin barrier) (SC)

Target
SC
Molecular classification
Other
01

Overview

The stratum corneum is the outermost layer of the epidermis and constitutes the primary skin barrier protecting the body from environmental insults, dehydration, pathogens, and allergens[1][4][5]. It is composed of terminally differentiated, enucleated keratinocytes called corneocytes, which are embedded in a lipid-rich extracellular matrix predominantly made of ceramides, cholesterol, and free fatty acids[2][3]. Key proteins such as filaggrin and involucrin, as well as structures like the cornified envelope and intercellular lipids, contribute to its structural and functional integrity[1][2][3]. The stratum corneum's acidic pH helps regulate enzyme function, maintain microbial balance, and facilitate enzymatic lipid processing[3]. Defects or disruption in this barrier (e.g., genetic filaggrin mutations, altered lipid content) are associated with diseases such as atopic dermatitis, contact dermatitis, and increased risk of skin infections[2][3]. While many drugs and therapies interact with the stratum corneum to enhance or repair barrier function, it is a tissue structure, not a discrete molecular target, so it is not considered a canonical therapeutic target in the usual sense[1][2][3][5]. Note: The "stratum corneum (skin barrier)" is not a molecule or receptor, but a specialized tissue structure. Therefore, it does not fit standard definitions of a drug target such as receptor, enzyme, or transporter. Its improvement or repair is a therapeutic goal, but it is not a single molecular target.

Other names
Stratum corneumskin barrierepidermal barrier
02

Mechanism of action

Reinforcement of barrier structure, anti-inflammatory, immunomodulation, hydration

03

Biological functions

Barrier functionpreventing water lossimmune defensephysical protection
04

Disease associations

Inflammationatopic dermatitisinfectionallergic sensitizationother
05

Safety considerations

Irritationallergic reactionsincreased susceptibility to infection upon barrier disruptionimpaired wound healing
06

Interacting drugs

Emollients

4 more in the full profile.

07

Biomarkers

Filaggrin expressionnatural moisturizing factors (NMF)ceramide contenttransepidermal water loss (TEWL)

Beyond the preview

Go deeper on Stratum corneum (skin barrier) (SC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratum corneum (skin barrier) (SC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call